Genomic insights for infectious diseases

Karius is a commercial-stage diagnostics company that is commercializing a liquid biopsy diagnostic test for infectious diseases. The Karius® Test is a blood test based on next-generation sequencing of microbial cell-free DNA. It can identify and quantify over 1,000 clinically relevant pathogens including bacteria, DNA viruses, fungi, and parasites. Applications include complicated pneumonia, infections in immunocompromised patients, and endocarditis. This is enabled by next generation sequencing of microbial cell-free DNA, proprietary molecular biology, and data analytics.

Investing partner / fund: